Postoperative Cognitive DysfunctionNOMICSNCT02979782
Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft
An observational study of Postoperative Cognitive Dysfunction and Cerebrovascular Accident, run by Jessa Hospital at 2 sites in Belgium.
Trial summary
Primary objectives: Assessment of the incidence of postoperative cognitive dysfunction (POCD), cerebrovascular accident (CVA), and delirium after minimal invasive coronary artery bypass grafting (Endo-CABG). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Postoperative Cognitive Dysfunction, Cerebrovascular Accident, Delirium
- What is being tested?
- Endo-CABG and PCI
- Type of treatment
- Surgery or procedure
- How many people
- 180 participants
- Where
- 2 sitesBelgium
- Study dates
- Dec 2016to Aug 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The population will be divided into three groups. The first group will be the Endo-CABG group which consist of the patients who undergo minimal invasive coronary artery bypass grafting. The second group consists of patients who will get an elective PCI intervention. this is a comparative group which is included to check whether the assessed prevalences in the Endo-CABG group are not related to underlying cardiac anomalies or to other cardiac intervention procedures. The third group consists of healthy volunteers. This control group will be included to eliminate natural variation in neurophysiological testing and to exclude the learning effect which can occur when repeated neurophysiological testing is performed.
Who may be able to join
- Minimum age of 18
- Elective Endo-CABG procedure (group 1)
- Elective PCI procedure (group 2)
- Elective healthy volunteer
Who cannot join
- Medical history of:
- Postoperative cognitive dysfunction, delirium or cerebrovascular accident
- symptomatic carotid artery disease
- Dementia
- Renal dysfunction: glomular filtration rate (GFR) < 30 ml/min
- Hepatic dysfunction: serum glutamic-oxaloacetic transaminase (SGOT)/ aspartate aminotransferase (AST), or serum glutamic-pyruvic transaminase (SGPT)/ alanine aminotransferase (ALT), more than three timer higher than normal limits
Show all 12Show fewer
- History of medication and alcohol abuse
- Language barrier or incapability to communicate
- Physical condition making participation impossible
- Participation in other clinical trials of a drug or medical instrument
- Surgical revision or intra-operative major cardial event (Endo-CABG group)
- Conversion to cardiac surgery or intra-operative major event (PCI group)
Trial locations and contacts
2 sites in 1 country.
Belgium2 sites
Jessa Hospital
Hasselt, Limburg, 3500
Jessaziekenhuis Hasselt
Hasselt, Limburg, 3500
About this study
Official title: Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft: a Single-centre Prospective Cohort Study
Primary objectives:
Assessment of the incidence of postoperative cognitive dysfunction (POCD), cerebrovascular accident (CVA), and delirium after minimal invasive coronary artery bypass grafting (Endo-CABG).
Secondary objectives:
- Quality of life, three months after endo-CABG
- Patient satisfaction with endo-CABG and the tests performed
- The influence of various demographic and peri-operative variables on neurological outcome after endo-CABG
- Incidence of fear and depression, 3 months after endo-CABG
Read the detailed description
Introduction:
Major improvements in surgical techniques, perfusion systems, and perioperative policies have led to improved quality of life of the patient, lower hospitalisation costs, and lower mortality rates in the field of cardiac surgery. However, despite these improvements and improved postoperative care, the neurological outcome after cardiac surgery remains a recurrent issue of interest. The most common neurological disorders after cardiac surgery are postoperative cognitive dysfunction (POCD), cerebrovascular accident (CVA), and delirium. After conventional cardiac surgery (invasive sternotomy procedure) the incidence of these neurological disorders is well studied. POCD has an incidence of 25-50%, CVA has an incidence of 1-5% and delirium has an incidence of 5-15%. These numbers prove that neurological outcome still is a major problem after cardiac surgery.
Postoperative cognitive dysfunction (POCD) is the most common neurological disorder after cardiac surgery. POCD is defined as a disturbance of the brain function, which is causally related to surgery. Due to the multifactorial nature of POCD it is difficult to pinpoint one major cause. testing of POCD is not standardised and is based on the '1995 statement of concensus on assessment of neurobehavioural outcomes after cardiac surgery'. This consensus statement describes the most reliable tests and study design to study POCD in clinical studies.
A battery of tests is described in the consensus statement:
- Rey auditory verbal learning test for verbal memory
- Trailmaking A and B for attention
- Grooved pegboard test for fine motor function
In this study, two additional tests will be performed to assess POCD:
the digit span test to test the short term verbal memory. the digit symbol-coding test to test the processing speed and memory of the patient.
Additional recommendations of the consensus statement to conduct reliable POCD testing are:
- Baseline testing
- At least on assessment of POCD three months postoperatively
- A control group and a comparative group
- The same person tests both pre- and postoperatively
- a clinical neurological investigation is necessary
Cerebrovascular accident (CVA or stroke) is caused by disturbances of the brain blood supply. The main causes of these disturbances are clotted vessels, hypoperfusion, or ruptured vessels in the brain. The risk of CVA is high in the first few days after cardiac surgery. CVA is diagnosed based on neurological evaluation and signs on CT or MRI scan.
Delirium is characterised by attention disorders and fluctuating changes in the mental state of the patient. Delirium is mainly related to surgery and can be diagnosed with the CAM-ICU (confusion assessment method for the intensive care unit).
These neurological complications have a negative effect on the quality of life, healthcare costs and mortality rate after cardiac surgery.
Recently, new developments in cardiac surgery hav led to the introduction of minimal invasive cardiac procedures into practice. These minimal invasive cardiac procedures are proven to be beneficial for the patient. Neurological outcome after minimal invasive cardiac surgery however, is not well studied.
Therefore, the main goal of this study is to examine the neurological outcome after endoscopic coronary artery bypass grafting (Endo-CABG). Endo-CABG is a minimal invasive cardiac procedure based on the conventional coronary artery bypass grafting (CABG) procedure.
Study design and study tests:
This study will be a single-centre prospective cohort study. The goal of the study is to assess the neurological outcome after endoscopic coronary artery bypass grafting (Endo-CABG). Three study groups will be included (described in section study groups), which will be tested for POCD, CVA and delirium.
Secondary outcomes in this research are quality of life of the patient (EQ-5D-5L), Fear and depression outcomes (VVO; CES-D), and assessment of demographic and peri-operative predictors of poor neurological outcome after endo-CABG.
Study tests:
Baseline tests will be performed in both intervention groups (Endo-CABG and PCI) and the healthy control group.
In the intervention groups the baseline preoperative tests will include:
- Baseline neurocognitive status: mini mental test
- Baseline EQ-5D: Quality of life
- Baseline fear and depression state (VVO; CES-D)
- Preoperative clinical neurological investigation
- Baseline POCD status (Rey auditory verbal learning test,Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)
For the healthy volunteers the same baseline tests will be performed, with exception of the neurological clinical evaluation.
Postoperative tests in the intervention groups will include:
- Postoperative neurologic clinical evaluation (CT scan if CVA suspected), CAM-ICU): these tests will be performed at the ICU or ward
- 3 months after surgery: EQ-5d (quality of life), Fear and depression, POCD follow-up (Rey auditory verbal learning test, Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)
For the healthy volunteers, the following tests will be performed 3 months after baseline testing:
- EQ-5d: quality of life
- Stroke follow-up
- Fear and depression
- POCD status (Rey auditory verbal learning test,Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)
Statistical analysis:
In this study POCD is defined as a decline in score between baseline and follow-up neurophysiological test, which should be higher than the natural variation. In this setting the natural learning effect will also be taken into account. To perform statistical analysis for POCD testing, Z-scores (or reliable change index (RCI)) will be used. The Z-score is a unit which indicates how the difference between the baseline score and the follow-up test behaves compared to the mean scores of the control group.
Thus, the individual RCI scores will be calculated as follows:
- For each patient, the baseline score from each test will be subtracted from the follow-up score, giving Δx. The same will be done in the control group, giving Δxc. The mean change on that test in the control group will then be subtracted from Δx to eliminate practice effects.
- This result will then be divided by the standard deviation of Δxc to eliminate the effect of natural variation in test performance. This is called a Z-score.
The RCI is the sum of the Z-scores of all tests.
We defined POCD in an individual patient as an RCI equal to or less than -1.645 (significance level 5%), or Z-score equal to or less than -1.645 in at least two different tests.
The group RCI scores will be compared using ANOVA or Kruskall-Wallis.
The quality of life will be tested using a mann-whitney U test at significance level 5%.
- Being tested
- Endo-CABG, PCI
- Keywords
- cardiac surgery, neurological outcome, minimal invasive coronary artery bypass graft (Endo-CABG)
- Medical subject headings
- Postoperative Cognitive Complications, Stroke, Delirium
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Endo-CABGProcedure or surgery
Also called minimal invasive Coronary Artery Bypass Grafting
minimal invasive cardiac intervention
PCIProcedure or surgery
Also called percutaneous coronary intervention
stenting procedure
| Study group | Role | What they receive |
|---|---|---|
| Endo-CABG, surgical group | the minimal invasive cardiac surgery group Receives: Procedure: Endo-CABG | |
| PCI, comparative surgical group | a comparative minimal invasive procedure Receives: Procedure: PCI | |
| Healthy volunteer, control group | to exclude any learning effect or natural variation in neurological testing |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of postoperative cognitive dysfunction
percentage of total study population
Measured: 3 months after intervention
Prevalence of delirium
percentage of total study population
Measured: 3 months after intervention
Prevalence of cerebrovascular accident
percentage of total study population
Measured: 3 months after intervention
Secondary outcomes (4)
Quality of life of the patient
assessment with the EQ-5D questionnaire
Measured: 3 months after intervention
assessment of predictors of poor neurological outcome after minimal invasive coronary artery bypass grafting
assessment of which demographic and peri-operative variables are associated with poor neurological outcome after minimal invasive coronary
Measured: 3 months after intervention
Incidence of depression after minimal invasive coronary artery bypass grafting
assessment with the CES-D questionnaire
Measured: 3 months after intervention
Incidence of fear after minimal invasive coronary artery bypass grafting
assessment with the Surgical Fear Questionnaire
Measured: 3 months after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Dec 2016 (estimated)
- Study startDec 2016
- Primary completionAug 2018
- Study completionAug 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for Postoperative Cognitive DysfunctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 180 participants (actual)
Sponsor and investigators
- Lead sponsor
- Jessa Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Hasselt University
- Responsible party
- Principal investigator, Stessel Björn, Jessa Hospital
- Investigators
- Björn Stessel, MD, PhD, Principal investigator, bjornstessel@hotmail.com
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02979782
- Sponsor's protocol ID
- 16.115/anesth16.01
- Acronym
- NOMICS
- Status last verified
- Dec 2018
- First submitted
- 23 Nov 2016
- Last updated
- 14 Dec 2018
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Undecided
Publications
Likosky DS, Nugent WC, Ross CS; Northern New England Cardiovascular Disease Study Group. Improving outcomes of cardiac surgery through cooperative efforts: the northern new England experience. Semin Cardiothorac Vasc Anesth. 2005 Jun;9(2):119-21. doi: 10.1177/108925320500900203.
PubMed 15920635GILMAN S. CEREBRAL DISORDERS AFTER OPEN-HEART OPERATIONS. N Engl J Med. 1965 Mar 11;272:489-98. doi: 10.1056/NEJM196503112721001. No abstract available.
PubMed 14250198Furlan AJ, Sila CA, Chimowitz MI, Jones SC. Neurologic complications related to cardiac surgery. Neurol Clin. 1992 Feb;10(1):145-66.
PubMed 1557000Jensen BO, Hughes P, Rasmussen LS, Pedersen PU, Steinbruchel DA. Health-related quality of life following off-pump versus on-pump coronary artery bypass grafting in elderly moderate to high-risk patients: a randomized trial. Eur J Cardiothorac Surg. 2006 Aug;30(2):294-9. doi: 10.1016/j.ejcts.2006.04.015. Epub 2006 Jul 7.
PubMed 16829089Newman MF, Grocott HP, Mathew JP, White WD, Landolfo K, Reves JG, Laskowitz DT, Mark DB, Blumenthal JA; Neurologic Outcome Research Group and the Cardiothoracic Anesthesia Research Endeavors (CARE) Investigators of the Duke Heart Center. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke. 2001 Dec 1;32(12):2874-81. doi: 10.1161/hs1201.099803.
PubMed 11739990Newman MF. Open heart surgery and cognitive decline. Cleve Clin J Med. 2007 Feb;74 Suppl 1:S52-5. doi: 10.3949/ccjm.74.suppl_1.s52. No abstract available.
PubMed 17455545Ottens TH, Dieleman JM, Sauer AM, Peelen LM, Nierich AP, de Groot WJ, Nathoe HM, Buijsrogge MP, Kalkman CJ, van Dijk D; DExamethasone for Cardiac Surgery (DECS) Study Group. Effects of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial. Anesthesiology. 2014 Sep;121(3):492-500. doi: 10.1097/ALN.0000000000000336.
PubMed 25225745Modi P, Chitwood WR Jr. Retrograde femoral arterial perfusion and stroke risk during minimally invasive mitral valve surgery: is there cause for concern? Ann Cardiothorac Surg. 2013 Nov;2(6):E1. doi: 10.3978/j.issn.2225-319X.2013.11.13.
PubMed 24350000Stessel B, Nijs K, Pelckmans C, Vandenbrande J, Ory JP, Yilmaz A, Starinieri P, Van Tornout M, De Klippel N, Dendale P. Neurological outcome after minimally invasive coronary artery bypass surgery (NOMICS): An observational prospective cohort study. PLoS One. 2020 Dec 23;15(12):e0242519. doi: 10.1371/journal.pone.0242519. eCollection 2020.
PubMed 33362277Nijs K, Vandenbrande J, Vaqueriza F, Ory JP, Yilmaz A, Starinieri P, Dubois J, Jamaer L, Arijs I, Stessel B. Neurological outcome after minimal invasive coronary artery surgery (NOMICS): protocol for an observational prospective cohort study. BMJ Open. 2017 Oct 6;7(10):e017823. doi: 10.1136/bmjopen-2017-017823.
PubMed 28988183
Study at a glance
From the registry record, last updated by the sponsor on 14 Dec 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft: a Single-centre Prospective Cohort Study
- ClinicalTrials.gov ID
- NCT02979782
- Acronym / sponsor ID
- NOMICS / 16.115/anesth16.01
- Keywords
- cardiac surgery, neurological outcome, minimal invasive coronary artery bypass graft (Endo-CABG)
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 180 participants (actual)
- Lead sponsor
- Jessa HospitalUniversity, hospital or other
- Collaborators
- Hasselt University
- Study start
- Dec 2016 (actual)
- Primary completion
- Aug 2018 (actual)
- Study completion
- Aug 2018 (actual)
- First posted
- 2 Dec 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Primary objectives:
Assessment of the incidence of postoperative cognitive dysfunction (POCD), cerebrovascular accident (CVA), and delirium after minimal invasive coronary artery bypass grafting (Endo-CABG).
Secondary objectives:
- Quality of life, three months after endo-CABG
- Patient satisfaction with endo-CABG and the tests performed
- The influence of various demographic and peri-operative variables on neurological outcome after endo-CABG
- Incidence of fear and depression, 3 months after endo-CABG
Detailed description
Introduction:
Major improvements in surgical techniques, perfusion systems, and perioperative policies have led to improved quality of life of the patient, lower hospitalisation costs, and lower mortality rates in the field of cardiac surgery. However, despite these improvements and improved postoperative care, the neurological outcome after cardiac surgery remains a recurrent issue of interest. The most common neurological disorders after cardiac surgery are postoperative cognitive dysfunction (POCD), cerebrovascular accident (CVA), and delirium. After conventional cardiac surgery (invasive sternotomy procedure) the incidence of these neurological disorders is well studied. POCD has an incidence of 25-50%, CVA has an incidence of 1-5% and delirium has an incidence of 5-15%. These numbers prove that neurological outcome still is a major problem after cardiac surgery.
Postoperative cognitive dysfunction (POCD) is the most common neurological disorder after cardiac surgery. POCD is defined as a disturbance of the brain function, which is causally related to surgery. Due to the multifactorial nature of POCD it is difficult to pinpoint one major cause. testing of POCD is not standardised and is based on the '1995 statement of concensus on assessment of neurobehavioural outcomes after cardiac surgery'. This consensus statement describes the most reliable tests and study design to study POCD in clinical studies.
A battery of tests is described in the consensus statement:
- Rey auditory verbal learning test for verbal memory
- Trailmaking A and B for attention
- Grooved pegboard test for fine motor function
In this study, two additional tests will be performed to assess POCD:
the digit span test to test the short term verbal memory. the digit symbol-coding test to test the processing speed and memory of the patient.
Additional recommendations of the consensus statement to conduct reliable POCD testing are:
- Baseline testing
- At least on assessment of POCD three months postoperatively
- A control group and a comparative group
- The same person tests both pre- and postoperatively
- a clinical neurological investigation is necessary
Cerebrovascular accident (CVA or stroke) is caused by disturbances of the brain blood supply. The main causes of these disturbances are clotted vessels, hypoperfusion, or ruptured vessels in the brain. The risk of CVA is high in the first few days after cardiac surgery. CVA is diagnosed based on neurological evaluation and signs on CT or MRI scan.
Delirium is characterised by attention disorders and fluctuating changes in the mental state of the patient. Delirium is mainly related to surgery and can be diagnosed with the CAM-ICU (confusion assessment method for the intensive care unit).
These neurological complications have a negative effect on the quality of life, healthcare costs and mortality rate after cardiac surgery.
Recently, new developments in cardiac surgery hav led to the introduction of minimal invasive cardiac procedures into practice. These minimal invasive cardiac procedures are proven to be beneficial for the patient. Neurological outcome after minimal invasive cardiac surgery however, is not well studied.
Therefore, the main goal of this study is to examine the neurological outcome after endoscopic coronary artery bypass grafting (Endo-CABG). Endo-CABG is a minimal invasive cardiac procedure based on the conventional coronary artery bypass grafting (CABG) procedure.
Study design and study tests:
This study will be a single-centre prospective cohort study. The goal of the study is to assess the neurological outcome after endoscopic coronary artery bypass grafting (Endo-CABG). Three study groups will be included (described in section study groups), which will be tested for POCD, CVA and delirium.
Secondary outcomes in this research are quality of life of the patient (EQ-5D-5L), Fear and depression outcomes (VVO; CES-D), and assessment of demographic and peri-operative predictors of poor neurological outcome after endo-CABG.
Study tests:
Baseline tests will be performed in both intervention groups (Endo-CABG and PCI) and the healthy control group.
In the intervention groups the baseline preoperative tests will include:
- Baseline neurocognitive status: mini mental test
- Baseline EQ-5D: Quality of life
- Baseline fear and depression state (VVO; CES-D)
- Preoperative clinical neurological investigation
- Baseline POCD status (Rey auditory verbal learning test,Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)
For the healthy volunteers the same baseline tests will be performed, with exception of the neurological clinical evaluation.
Postoperative tests in the intervention groups will include:
- Postoperative neurologic clinical evaluation (CT scan if CVA suspected), CAM-ICU): these tests will be performed at the ICU or ward
- 3 months after surgery: EQ-5d (quality of life), Fear and depression, POCD follow-up (Rey auditory verbal learning test, Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)
For the healthy volunteers, the following tests will be performed 3 months after baseline testing:
- EQ-5d: quality of life
- Stroke follow-up
- Fear and depression
- POCD status (Rey auditory verbal learning test,Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)
Statistical analysis:
In this study POCD is defined as a decline in score between baseline and follow-up neurophysiological test, which should be higher than the natural variation. In this setting the natural learning effect will also be taken into account. To perform statistical analysis for POCD testing, Z-scores (or reliable change index (RCI)) will be used. The Z-score is a unit which indicates how the difference between the baseline score and the follow-up test behaves compared to the mean scores of the control group.
Thus, the individual RCI scores will be calculated as follows:
- For each patient, the baseline score from each test will be subtracted from the follow-up score, giving Δx. The same will be done in the control group, giving Δxc. The mean change on that test in the control group will then be subtracted from Δx to eliminate practice effects.
- This result will then be divided by the standard deviation of Δxc to eliminate the effect of natural variation in test performance. This is called a Z-score.
The RCI is the sum of the Z-scores of all tests.
We defined POCD in an individual patient as an RCI equal to or less than -1.645 (significance level 5%), or Z-score equal to or less than -1.645 in at least two different tests.
The group RCI scores will be compared using ANOVA or Kruskall-Wallis.
The quality of life will be tested using a mann-whitney U test at significance level 5%.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Endo-CABG, surgical group | – | Procedure: Endo-CABGthe minimal invasive cardiac surgery group |
| PCI, comparative surgical group | – | Procedure: PCIa comparative minimal invasive procedure |
| Healthy volunteer, control group | – | –to exclude any learning effect or natural variation in neurological testing |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The population will be divided into three groups. The first group will be the Endo-CABG group which consist of the patients who undergo minimal invasive coronary artery bypass grafting. The second group consists of patients who will get an elective PCI intervention. this is a comparative group which is included to check whether the assessed prevalences in the Endo-CABG group are not related to underlying cardiac anomalies or to other cardiac intervention procedures. The third group consists of healthy volunteers. This control group will be included to eliminate natural variation in neurophysiological testing and to exclude the learning effect which can occur when repeated neurophysiological testing is performed.
Key inclusion criteria (4 listed)
- Minimum age of 18
- Elective Endo-CABG procedure (group 1)
- Elective PCI procedure (group 2)
- Elective healthy volunteer
Key exclusion criteria (12 listed)
- Medical history of:
- Postoperative cognitive dysfunction, delirium or cerebrovascular accident
- symptomatic carotid artery disease
- Dementia
- Renal dysfunction: glomular filtration rate (GFR) < 30 ml/min
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Endo-CABGAlso: minimal invasive Coronary Artery Bypass Graftingminimal invasive cardiac intervention | Procedure or surgery | Endo-CABG, surgical group |
| PCIAlso: percutaneous coronary interventionstenting procedure | Procedure or surgery | PCI, comparative surgical group |
Primary outcome
Prevalence of postoperative cognitive dysfunction
Time frame: 3 months after intervention
percentage of total study population
Prevalence of delirium
Time frame: 3 months after intervention
percentage of total study population
Prevalence of cerebrovascular accident
Time frame: 3 months after intervention
percentage of total study population
4 secondary outcomes
Quality of life of the patient
Time frame: 3 months after intervention
assessment of predictors of poor neurological outcome after minimal invasive coronary artery bypass grafting
Time frame: 3 months after intervention
Incidence of depression after minimal invasive coronary artery bypass grafting
Time frame: 3 months after intervention
Incidence of fear after minimal invasive coronary artery bypass grafting
Time frame: 3 months after intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Dec 2018.
- Background: PubMed 15920635Likosky DS, Nugent WC, Ross CS; Northern New England Cardiovascular Disease Study Group. Improving outcomes of cardiac surgery through cooperative efforts: the northern new England experience. Semin Cardiothorac Vasc Anesth. 2005 Jun;9(2):119-21. doi: 10.1177/108925320500900203.
- Background: PubMed 14250198GILMAN S. CEREBRAL DISORDERS AFTER OPEN-HEART OPERATIONS. N Engl J Med. 1965 Mar 11;272:489-98. doi: 10.1056/NEJM196503112721001. No abstract available.
- Background: PubMed 1557000Furlan AJ, Sila CA, Chimowitz MI, Jones SC. Neurologic complications related to cardiac surgery. Neurol Clin. 1992 Feb;10(1):145-66.
- Background: PubMed 16829089Jensen BO, Hughes P, Rasmussen LS, Pedersen PU, Steinbruchel DA. Health-related quality of life following off-pump versus on-pump coronary artery bypass grafting in elderly moderate to high-risk patients: a randomized trial. Eur J Cardiothorac Surg. 2006 Aug;30(2):294-9. doi: 10.1016/j.ejcts.2006.04.015. Epub 2006 Jul 7.
- Background: PubMed 11739990Newman MF, Grocott HP, Mathew JP, White WD, Landolfo K, Reves JG, Laskowitz DT, Mark DB, Blumenthal JA; Neurologic Outcome Research Group and the Cardiothoracic Anesthesia Research Endeavors (CARE) Investigators of the Duke Heart Center. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke. 2001 Dec 1;32(12):2874-81. doi: 10.1161/hs1201.099803.
- Background: PubMed 17455545Newman MF. Open heart surgery and cognitive decline. Cleve Clin J Med. 2007 Feb;74 Suppl 1:S52-5. doi: 10.3949/ccjm.74.suppl_1.s52. No abstract available.
- Background: PubMed 25225745Ottens TH, Dieleman JM, Sauer AM, Peelen LM, Nierich AP, de Groot WJ, Nathoe HM, Buijsrogge MP, Kalkman CJ, van Dijk D; DExamethasone for Cardiac Surgery (DECS) Study Group. Effects of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial. Anesthesiology. 2014 Sep;121(3):492-500. doi: 10.1097/ALN.0000000000000336.
- Background: PubMed 24350000Modi P, Chitwood WR Jr. Retrograde femoral arterial perfusion and stroke risk during minimally invasive mitral valve surgery: is there cause for concern? Ann Cardiothorac Surg. 2013 Nov;2(6):E1. doi: 10.3978/j.issn.2225-319X.2013.11.13.
- Derived from this study: PubMed 33362277Stessel B, Nijs K, Pelckmans C, Vandenbrande J, Ory JP, Yilmaz A, Starinieri P, Van Tornout M, De Klippel N, Dendale P. Neurological outcome after minimally invasive coronary artery bypass surgery (NOMICS): An observational prospective cohort study. PLoS One. 2020 Dec 23;15(12):e0242519. doi: 10.1371/journal.pone.0242519. eCollection 2020.
- Derived from this study: PubMed 28988183Nijs K, Vandenbrande J, Vaqueriza F, Ory JP, Yilmaz A, Starinieri P, Dubois J, Jamaer L, Arijs I, Stessel B. Neurological outcome after minimal invasive coronary artery surgery (NOMICS): protocol for an observational prospective cohort study. BMJ Open. 2017 Oct 6;7(10):e017823. doi: 10.1136/bmjopen-2017-017823.
- Individual participant dataSharing planned: Undecided
Related trials for Postoperative Cognitive Dysfunction
Not yet recruiting
Prediction and Prevention of Postoperative Mortality and Morbidity
Dementia, Postoperative Delirium (POD)
Active, not recruitingObservational study
Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor
Cognitive Decline, Urinary Bladder Cancer
Active, not recruitingObservational study
The Effect of Single Lung Ventilation Duration and Intraoperative Brain Oxygenation on Cognitive Function and Postoperative Pain in Geriatric Patients
Thoracic Anesthesia, Geriatric Anesthesia
Not yet recruitingPhase 4
Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery
Aortic Aneurysm of the Proximal Arch, Aortic Aneurysms Arch
Enrolling by invitationPhase 4
Effects of Ciprofol on Perioperative Neurocognitive Function in Elderly Patients Undergoing Daytime Surgery
PND, POCD - Postoperative Cognitive Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Björn Stessel, MD, PhD principal investigator
bjornstessel@hotmail.com
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Postoperative Cognitive Dysfunction and Cerebrovascular Accident, run by Jessa Hospital at 2 sites in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of postoperative cognitive dysfunction (time frame: 3 months after intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02979782, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2018.